Vernalis plc today announces its decision to cease further investment in V3381. An interim review of data from the small pilot study in chronic cough being undertaken in collaboration with Professor ...
5don MSN
AstraZeneca PLC (NASDAQ:AZN) announces strategic collaboration agreement with CSPC Pharmaceuticals
AstraZeneca PLC (NASDAQ:AZN) is one of the best long term low volatility stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) ...
LONDON, UK / ACCESSWIRE / November 1, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company targeting diseases with a high unmet ...
RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares ...
LEEDS, England, July 25, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its oncology programmes.
LONDON, UK / ACCESSWIRE / June 29, 2023 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focusing on infectious and other prevalent ...
Dublin / London, 3 July 2024: Cairn Homes plc ("Cairn", "the Company" or "the Group") (Euronext Dublin: C5H / LSE: CRN), today announces following the release of its H1 2024 Trading Update earlier ...
Hosted on MSN
Informa PLC updates on £350m share buyback programme
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
On 10 June 2025 FirstGroup plc (the ‘Group’) announced an on-market share buyback programme to purchase up to £50m of ordinary shares (the ’Programme’), which commenced on 10 June 2025. The Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results